Cargando…
Long-Term Mortality after New-Onset Atrial Fibrillation in COVID-19
Background: Atrial fibrillation (AF) has been described as a common cardiovascular manifestation in patients suffering from coronavirus disease 2019 (COVID-19) and has been suggested to be a potential risk factor for a poor clinical outcome. Methods: In this observational study, all patients hospita...
Autores principales: | Jurisic, Stjepan, Komminoth, Mathis, Todorov, Atanas, Bertschi, Daniela A., Jurisic, Martin, Vranjic, Ivica, Wiggli, Benedikt, Schmid, Hansruedi, Gebhard, Catherine, Gebhard, Caroline E., Heidecker, Bettina, Beer, Jürg-Hans, Patriki, Dimitri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146060/ https://www.ncbi.nlm.nih.gov/pubmed/37109261 http://dx.doi.org/10.3390/jcm12082925 |
Ejemplares similares
-
MALE SEX, HLA-C*04:01 AND COVID-19: A RISKY CONSTELLATION
por: Suwalski, Phillip, et al.
Publicado: (2022) -
Serum Catestatin Concentrations Are Increased in Patients with Atrial Fibrillation
por: Katic, Josip, et al.
Publicado: (2023) -
Association of Electrical Cardioversion with Brain Perfusion and Cognitive Function in Patients with Atrial Fibrillation
por: Kedžo, Josip, et al.
Publicado: (2023) -
Epidemiological Impact of Myocarditis
por: Golpour, Ainoosh, et al.
Publicado: (2021) -
Neurologic Biomarkers, Neuroimaging, and Cognitive Function in Persistent Atrial Fibrillation: A Cross-Sectional Study
por: Kedžo, Josip, et al.
Publicado: (2023)